![Mats-Olof Wallin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mats-Olof Wallin
Directeur Financier/CFO chez
OxThera AB
Profil
Mats-Olof Wallin is currently the Chief Financial Officer & Deputy CEO at OxThera AB since 2020.
Prior to this, he worked as the CFO & Director-Investor Relations at Biotage AB from 2003 to 2012, the Chief Financial Officer at Karo Healthcare AB from 2018 to 2019, and the Chief Financial Officer & Senior Vice President at Swedish Orphan Biovitrum AB from 2013 to 2018.
He completed his undergraduate degree from the University of Uppsala.
Postes actifs de Mats-Olof Wallin
| Sociétés | Poste | Début |
|---|---|---|
OxThera AB
 OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Directeur Financier/CFO | 01/01/2020 |
Anciens postes connus de Mats-Olof Wallin
| Sociétés | Poste | Fin |
|---|---|---|
| KARO PHARMA AB (PUBL) | Directeur Financier/CFO | 01/10/2019 |
| SWEDISH ORPHAN BIOVITRUM AB | Directeur Financier/CFO | 20/07/2018 |
| BIOTAGE AB | Directeur Financier/CFO | 01/01/2012 |
Formation de Mats-Olof Wallin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Karo Healthcare AB
 Karo Healthcare AB Household/Personal CareConsumer Non-Durables Manufactures skincare products, cosmetics, supplements and digestive pharmaceuticals | Consumer Non-Durables |
Biotage AB
 Biotage AB Medical SpecialtiesHealth Technology Develops workflow solutions, instruments and consumables used in drug discovery & pharmaceutical development | Health Technology |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
